Stay updated on PK and QTc Interaction in Sitravatinib Clinical Trial
Sign up to get notified when there's something new on the PK and QTc Interaction in Sitravatinib Clinical Trial page.

Latest updates to the PK and QTc Interaction in Sitravatinib Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check55 days agoChange DetectedThe web page has been updated to reflect a new study design for a Phase 1 trial involving advanced solid tumors, with a focus on drug-drug interactions and QTc effects, while removing detailed descriptions of the previous study's methodology and criteria.SummaryDifference15%
- Check69 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check112 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to PK and QTc Interaction in Sitravatinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and QTc Interaction in Sitravatinib Clinical Trial page.